- Report
- December 2024
- 198 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- November 2024
- 209 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- September 2024
- 179 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- August 2024
- 184 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- July 2024
- 138 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- July 2024
- 174 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- July 2024
- 134 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- June 2024
- 171 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- June 2024
- 162 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- May 2024
- 160 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- May 2024
- 170 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- April 2025
- 246 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- February 2025
- 185 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- September 2024
- 183 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- April 2024
- 180 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- March 2025
- 185 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- March 2025
- 180 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- March 2025
- 182 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- February 2025
- 180 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- February 2025
- 180 Pages
Global
From €4095EUR$4,500USD£3,511GBP

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists.
The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more